Join
Live feed
·
PRReleasevia Quantisnow
ANI Pharmaceuticals Inc. logo

ANI Pharmaceuticals Announces Results from NEW DAY Clinical Trial of ILUVIEN® for Use in Patients with Diabetic Macular Edema (DME)

ByQuantisnow·Wall Street's wire, on your screen.
ANIP· ANI Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ANIP (ANI Pharmaceuticals Inc.) and more on Quantisnow.